CD Markers
CD39


Topic Completed: 1 January 2011

Minor changes: 2 October 2020

Copyright: 2002-2021, PathologyOutlines.com, Inc.

PubMed Search: CD39 [title]

Nat Pernick, M.D.
Page views in 2020: 172
Page views in 2021 to date: 13
Cite this page: Pernick N. CD39. PathologyOutlines.com website. https://www.pathologyoutlines.com/topic/cdmarkerscd39.html. Accessed January 15th, 2021.
Definition / general
  • Endothelial ATPase that blocks platelet activation
Terminology
  • Also called ectonucleoside triphosphate diphosphohydrolase (NTPDase-1)
Pathophysiology
  • Plasma membrane-bound enzyme that hydrolyzes extracellular ATP and ADP to AMP (Platelets 2005;16:159), and acts as important inhibitor of platelet activation by blocking platelet aggregation responses to ADP
  • Also degrades the extracellular ATP released during tissue injury, which otherwise would trigger inflammation
  • Highly expressed on regulatory Foxp3(+) CD4 T cells
  • May have a therapeutic anti-thrombotic effect (Semin Thromb Hemost 2005;31:234)
  • Its biochemical activity is lost at sites of acute vascular injury, such as in ischemia reperfusion and immune graft rejection (Blood Cells Mol Dis 2006;36:217)
  • Also regulates vascular and immune cell adhesion and signaling events pivotal in inflammation (Biochem J 2006;396:23)
Clinical features
Uses by pathologists
  • No significant clinical use by pathologists
Microscopic (histologic) images

Image hosted on other servers:
Missing Image

Donor liver

Positive staining - normal
Additional references
Back to top
Image 01 Image 02